Tolerance of an Immersive Virtual Reality Task Evaluating the Spatial Memory of Elderly Subjects

NCT05996250 | Completed

• 1 other identifier: 69HCL22_0203
• Study Type: interventional
• Target: 84
• Locations: 1 country
• Sites: 1

Brief Summary

Spatial navigation is a high-level cognitive function allowing animals and humans to orient and move in space by constructing a mental representation of the environment. This function has been identified as one of the very first to be affected by Alzheimer's disease, including at the early stages, before the appearance of other mnesic disorders that the latter causes, such as those of episodic memory. However, the neuropsychological tests currently used in the diagnosis of cognitive disorders do not allow effective assessment of spatial memory impairment, in particular because it is impractical to offer spatial orientation tasks in a consulting room. In this context, virtual reality offers very interesting perspectives: it makes it possible to create controlled environments to assess spatial memory, without leaving the place of consultation. Before being able to test its possible diagnostic efficacy, it is imperative to test the feasibility as well as the reliability of this type of task on an elderly population with no cognitive impairment. The data currently available on immersion tolerance in virtual reality mainly concern young people aged 18 to 35 and little data is available concerning the elderly or very old. If this task correctly assesses spatial navigation abilities, this study should find the effects of age and sex usually observed. The aim of this study is to assess the tolerance of an immersive virtual reality task evaluating the spatial memory of elderly subjects and the effects of age, gender and level of education on performance.

Conditions

Healthy Participants

Keywords

Virtual reality; ageing; spatial memory

Outcome Measures

Primary Outcomes (1)

• Sickness Simulator Questionnaire (SSQ) score

  This is a questionnaire composed of 16 items covering the potential symptoms of intolerance to a virtual reality tool. Each item is rated 0 (no symptom), 1 (mild symptom), 2 (moderate symptom) or 3 (severe symptom). The total score is obtained by multiplying the sum of the items by 3.74, and therefore varies from 0 to 180.

  The sickness simulator scale is assessed immediately after the immersive virtual reality task.

Secondary Outcomes (4)

• Time to complete the task in immersive virtual reality according to the age of the participants

  through study completion, 1 year

• Time to complete the task in immersive virtual reality (in seconds) according to the gender of participants (male or female)

  through study completion, 1 year

• Time to complete the task in immersive virtual reality according to the number of years of study

  through study completion, 1 year

• Raw score on the Wechsler Memory Scale-III (MEM III) Spatial Memory subtest

  through study completion, 1 year

Study Arms (1)

Immersive virtual reality task

OTHER

The immersive virtual reality task, specifically designed for this research, is an adaptation to humans of Morris Pool. The virtual environment is composed of a circular arena 22 virtual meters in diameter, delimited by a low wall. It features two visual landmarks and an invisible object to find. The activity includes a control training sequence, an evaluation sequence and a delayed recall performed approximately 20 minutes after the end of the evaluation sequence. The immersive reality task is performed once by the participants (the study consists on one visit).

Other: Immersive virtual reality task

Interventions

Immersive virtual reality task OTHER

participants will have to wear a virtual reality headset connected to a remote control and will have to perform submersive virtual reality tasks

Immersive virtual reality task

Eligibility Criteria

• Age: 60 Years - 85 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Participant aged 60 to 85
• Participant affiliated or entitled to a social security scheme
• Recruited participants must have been informed and consented in writing

You may not qualify if:

• Participant with a diagnosis of cognitive impairment
• Severe, progressive or unstable pathology whose nature may interfere with the evaluation variables (epilepsy, psychiatric or psychotic disorders in the acute phase, visual hallucinations, acute infection, lack of sleep)
• Participant equipped with a pacemaker
• Burns or sores on the upper part of the face or on the scalp
• Consumption of toxic substances that can influence cognitive performance
• Deafness or blindness that may compromise participant assessment or completion of tasks and scales
• Participant under guardianship or curatorship or legal safeguard
• Participant refusing to use an immersive virtual reality tool
• Criterion for stopping the procedure under study: stopping the virtual reality task due to the participant's simulator sickness.
• Montreal Cognitive Assessment (MOCA) score less than 26
• MacNair Subjective Complaint Scale score greater than 16
• AGGIR score (Autonomy, Gerontology Group Iso Resources) less than 5

Sponsors & Collaborators

• Hospices Civils de Lyon: lead

Study Sites (1)

Charpennes Geriatric Hospital, Lyon University Hospital

Villeurbanne, 69100, France

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 1, 2023
• First Posted: August 18, 2023
• Study Start: September 25, 2023
• Primary Completion: May 28, 2024
• Study Completion: May 28, 2024
• Last Updated: June 5, 2024

Record last verified: 2024-06

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)